Skip Nav Destination
Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma
The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients
Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells
Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions
Issue Archive
Table of Contents
INSIDE BLOOD
REVIEW ARTICLE
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia/lymphoma
Clinical Trials & Observations
Yu Sawada,Ryosuke Hino,Kayo Hama,Shun Ohmori,Haruna Fueki,Shigenori Yamada,Shoko Fukamachi,Makiko Tajiri,Rieko Kubo,Manabu Yoshioka,Daiki Nakashima,Kazunari Sugita,Ryutaro Yoshiki,Takatoshi Shimauchi,Tomoko Mori,Kunio Izu,Miwa Kobayashi,Motonobu Nakamura,Yoshiki Tokura
The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis
Clinical Trials & Observations
Jasper H. Smalberg,Edith Koehler,Sarwa Darwish Murad,Aurelie Plessier,Susana Seijo,Jonel Trebicka,Massimo Primignani,Moniek P. M. de Maat,Juan-Carlos Garcia-Pagan,Dominique C. Valla,Harry L. A. Janssen,Frank W. G. Leebeek,for the European Network for Vascular Disorders of the Liver (EN-Vie)
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma
Clinical Trials & Observations
Katrien Van Roosbroeck,Luk Cox,Thomas Tousseyn,Idoya Lahortiga,Olga Gielen,Barbara Cauwelier,Pascale De Paepe,Gregor Verhoef,Peter Marynen,Peter Vandenberghe,Chris De Wolf-Peeters,Jan Cools,Iwona Wlodarska
LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients
Clinical Trials & Observations
Hatice Duzkale,Carmen D. Schweighofer,Kevin R. Coombes,Lynn L. Barron,Alessandra Ferrajoli,Susan O'Brien,William G. Wierda,John Pfeifer,Tadeusz Majewski,Bogdan A. Czerniak,Jeffrey L. Jorgensen,L. Jeffrey Medeiros,Emil J Freireich,Michael J. Keating,Lynne V. Abruzzo
GENE THERAPY
HEMATOPOIESIS AND STEM CELLS
Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells
e-blood
Motohiko Oshima,Mitsuhiro Endoh,Takaho A. Endo,Tetsuro Toyoda,Yaeko Nakajima-Takagi,Fumihiro Sugiyama,Haruhiko Koseki,Michael Kyba,Atsushi Iwama,Mitsujiro Osawa
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
c-JUN promotes BCR-ABL–induced lymphoid leukemia by inhibiting methylation of the 5′ region of Cdk6
Karoline Kollmann,Gerwin Heller,Rene Georg Ott,Ruth Scheicher,Eva Zebedin-Brandl,Christine Schneckenleithner,Olivia Simma,Wolfgang Warsch,Eva Eckelhart,Andrea Hoelbl,Martin Bilban,Sabine Zöchbauer-Müller,Marcos Malumbres,Veronika Sexl
MYELOID NEOPLASIA
Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions
e-blood
Samuel Quentin,Wendy Cuccuini,Raphael Ceccaldi,Olivier Nibourel,Corinne Pondarre,Marie-Pierre Pagès,Nadia Vasquez,Catherine Dubois d'Enghien,Jérôme Larghero,Régis Peffault de Latour,Vanderson Rocha,Jean-Hugues Dalle,Pascale Schneider,Mauricette Michallet,Gérard Michel,André Baruchel,François Sigaux,Eliane Gluckman,Thierry Leblanc,Dominique Stoppa-Lyonnet,Claude Preudhomme,Gérard Socié,Jean Soulier
RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
VASCULAR BIOLOGY
-
Cover Image
Cover Image
“In situ” follicular lymphoma is identifiable by the strong expression of BCL2 and CD10. Immunohistochemistry shows strong positive staining for BCL2 and CD10 in the majority of follicles. The BCL2 expression is much brighter than in the surrounding mantle cells. The CD10+ cells are confined only to germinal centers and are not seen in the interfollicular region or elsewhere in the lymph node. See the article by Carbone and Santoro on page 3954.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals